GlycoMimetics, Inc. GlycoMimetics, Inc. specializes in the rational design of small molecule therapeutics that mimic the functions of bioactive carbohydrates.
 
GlycoMimetics, Inc. In the News
 

Washington Business Journal - GlycoMimetics completes drug trial

Washington Business Journal - GlycoMimetics’ sickle cell drug enters human tests

Washington Business Journal - GlycoMimetics Chief Named to Biotech Institute's Board

Windhover Start-Up Magazine - Glycobiology's Second Wave

The Washington Post - GlycoMimetics' Research Taps Troublesome Carbohydrates to Combat Diseases

Signals Magazine - Glycobiology: Biotech's New Sweet Spot

 
Site Map | Copyright © 2009 | Contact Us